Abstract

ObjectiveWe aim to analyse sex-specific differences in aortic valves (AVs) and valve interstitial cells (VICs) from aortic stenosis (AS) patients.Approach and Results238 patients with severe AS undergoing surgical valve replacement were recruited. Two hundred and two AVs (39.1% women) were used for ex vivo analyses and 36 AVs (33.3% women) for in vitro experiments. AVs from men presented increased levels of the inflammatory molecules interleukin (IL)-1β, IL-6, Rantes, and CD45. Oxidative stress (eNOS, myeloperoxidase, malondialdehyde and nitrotyrosine) was upregulated in male AVs. Concerning fibrosis, similar levels of collagen type I, decreased levels of collagen type III and enhanced fibronectin, active Lox-1 and syndecan-1 expressions were found in AVs from men compared with women. Extracellular matrix (ECM) remodeling was characterized by reduced metalloproteinase-1 and 9 expression and increased tissue inhibitor of metalloproteinase-2 expression in male AVs. Importantly, osteogenic markers (bone morphogenetic protein-9, Rank-L, osteopontin, periostin, osteocalcin and Sox-9) and apoptosis (Bax, Caspase 3, p53, and PARP1) were enhanced in AVs from men as compared to women. Isolated male VICs presented higher myofibroblast-like phenotype than female VICs. Male VICs exhibited increased inflammatory, oxidative stress, fibrotic, apoptosis and osteogenic differentiation markers.ConclusionsOur results suggest that the mechanisms driving the pathogenesis of AS could be different in men and women. Male AVs and isolated VICs presented more inflammation, oxidative stress, ECM remodeling and calcification as compared to those from women. A better knowledge of the pathophysiological pathways in AVs and VICs will allow the development of sex-specific options for the treatment of AS.

Highlights

  • Aortic stenosis (AS) is the most prevalent form of heart valve disease

  • The overall use of statin was significantly higher in men, whilst the intake of diuretic drugs was in women

  • We investigated the expression of molecules involved in extracellular matrix (ECM) degradation including Matrix metalloproteinase (MMP) and their inhibitors (TIMPs)

Read more

Summary

Introduction

Aortic stenosis (AS) is the most prevalent form of heart valve disease. It is present in 2% to 7% of individuals older than 65 years (12.4% in European population >75) and the 2-year mortality rate rises up to 50% when AS becomes symptomatic [1, 2]. Valve resident cells, including the valve interstitial and endothelial cells (VIC and VEC, respectively) play a key role in the pathogenesis of AS [5]. VICs are a heterogeneous cell population which under pathological conditions become myofibroblasts-like cells. As a result, misbalanced extracellular matrix (ECM) synthesis and degradation, namely ECM remodeling, and inflammation trigger VICs apoptosis, oxidative stress, all of them leading to extensive calcification of the AV cusps [5, 6]. Despite recent advances in the knowledge of the pathophysiology of AS, there are no current pharmacologic-based therapies available, only the replacement of the naïve valve [7]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call